Lilly Is Selling Zepbound Vials at 50% Discount to Shots
Bloomberg Businessweek
Pharmaceutical Innovation in Weight Loss Drugs
This chapter examines a pharmaceutical company's strategic decision to offer weight loss medications in vials at a discount, particularly focusing on Medicare patients. It highlights the innovative direct-to-consumer distribution model and the implications of cash payments outside traditional insurance coverage. The chapter also discusses the growing popularity of GLP-1 weight loss drugs and the evolving landscape of the pharmaceutical industry as companies shift to direct sales channels.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
